Skip to main content

Table 1 Patient characteristics based on primary chemotherapy received

From: Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study

Parameters Cisplatin (n = 66) Cetuximab (n = 55)
Sex
 Male 51 39
 Female 15 16
Age   
 >  60 18 33
 ≤ 60 48 22
Mean ± SD (Overall 60.09 ± 10.28)  56.80 ± 9.10 60.04 ± 10.30
HPV/p16
 Positive 34 21
 Negative 9 7
 Not available 23 27
Primary
 Oropharynx 55 45
 Hypopharynx/Larynx 5 7
 Oral Cavity 5 2
 Other 1 1
Elevated baseline creatinine (> 1.3 mg/dL)
 Yes 14 13
 No 43 38
 Not Available 9 4
Smoking
 Smoker 44 32
 Light (< 10 Pack-Years) 10 4
Heavy (≥ 10 Pack-Years) 26 25
 Unknown Pack-Years 8 3
 Non-Smoker 21 21
 Not Available 1 2
Comorbidities
 Yes (≥ 2 Conditions) 48 35
 No (< 2 Conditions) 16 16
 Not Available 2 4
T Staging
 T1 6 11
 T2 26 20
 T3 20 14
 T4 12 9
 Tx 2 1
N staging
 N0 3 7
 N1 8 8
 N2 46 36
 N3 7 2
 Nx 2 2
M staging
 M0 60 51
 M1 0 0
 Mx 6 4